Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division Sort ascending
  • Business
  • Functional Area
  • Date Posted
Job Title Site Location Division Sort ascending Business Functional Area Date Posted
FRA Technical Accounting & Special Projects APMA Selangor Malaysia Operations CTS Audit & Finance Aug 22, 2024
SAP Security Manager Prague Czech Republic Operations CTS Audit & Finance Jul 22, 2024
ERP Assurance Senior Consultant Selangor Malaysia Operations CTS Audit & Finance Jul 17, 2024
P2P Process Excellence INSURGENTES Mexico Operations CTS Audit & Finance Oct 02, 2024
Procure to Pay Business Partner US Temporary INSURGENTES Mexico Operations CTS Audit & Finance Oct 22, 2024
LDC Adopt Process Lead - Taxes INSURGENTES Mexico Operations CTS Audit & Finance Aug 19, 2024
TCM Senior Cash Management Specialist INSURGENTES Mexico Operations CTS Audit & Finance Aug 30, 2024
Record to Report Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Record to Report Sr Specialist Intercompany INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Record to Report Sr Specialist US INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Fixed Assets Sr Specialist INSURGENTES Mexico Operations CTS Audit & Finance Sep 10, 2024
Commercial BPA Manager Montreal Canada International Innovative Medicines Audit & Finance Oct 08, 2024
Chef commercial BPA Montreal Canada International Innovative Medicines Audit & Finance Oct 08, 2024
Financial Accounting Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Sep 13, 2024
Tax Manager m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany Finance Corporate Audit & Finance Oct 16, 2024
R2R Lead Israel Israel Israel Finance CTS Audit & Finance Sep 16, 2024
Financial Analyst - SoD Ops Hyderabad (Office) India Finance Corporate Audit & Finance Sep 17, 2024
RLT Sasayama_Associate_Finance Business Planning and Analysis Sasayama Japan Finance Innovative Medicines Audit & Finance Sep 17, 2024
Senior Manager ERP Assurance Hyderabad (Office) India Finance CTS Audit & Finance Sep 23, 2024
S2P Business Partner (Korean speaker) Selangor Malaysia Finance CTS Audit & Finance Sep 24, 2024
BPA Planning Process, RLT Baarle Nassau Netherlands Finance Innovative Medicines Audit & Finance Aug 05, 2024
Treasury & Cash Management Team Lead Selangor Malaysia Finance CTS Audit & Finance Aug 12, 2024
R2R Senior Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Oct 02, 2024
Site Finance Head Morris Plains USA Finance Innovative Medicines Audit & Finance Oct 04, 2024
Senior FRA Specialist GL Prague Czech Republic Finance CTS Audit & Finance Sep 26, 2024
Comptable Général(e) Expérimenté(e) H/F Paris Headquarter (Novartis Pharma S.A.S.) France Finance CTS Audit & Finance Sep 27, 2024
R2R Senior Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 08, 2024
Expert Analyst – Management Reporting Prague Czech Republic Finance Corporate Audit & Finance Oct 08, 2024
Global Finance Master Data Sr Specialist INSURGENTES Mexico Finance CTS Audit & Finance Oct 08, 2024
BPA & R2R Analyst Amsterdam Netherlands Finance Innovative Medicines Audit & Finance Sep 04, 2024
R2R Senior Specialist Bucuresti Romania Finance CTS Audit & Finance Sep 05, 2024
Associate Director, US Federal and State Tax Reporting East Hanover USA Finance Corporate Audit & Finance Sep 06, 2024
Treasury Manager Moscow (City) Russian Fed. Finance CTS Audit & Finance Jun 20, 2024
R2R Accountant Moscow (City) Russian Fed. Finance CTS Audit & Finance Oct 22, 2024
Revenue Accounting Manager Shanghai (Shanghai) China Finance CTS Audit & Finance Jul 17, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance Oct 06, 2024
R2R Team Lead - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Oct 10, 2024
BPA (Budget & Planning Analyst) İstanbul Kurtköy Turkey Finance Innovative Medicines Audit & Finance Oct 10, 2024
R2R Senior Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Aug 19, 2024
ERP Assurance Senior Consultant-2 INSURGENTES Mexico Finance CTS Audit & Finance Aug 20, 2024
Business Planning and Analysis Manager, Novartis Technical Operations INSURGENTES Mexico Finance Innovative Medicines Audit & Finance Aug 22, 2024
Corporate Tax Manager Amiria Egypt Finance Corporate Audit & Finance May 31, 2024
P2P & T&E Specialist (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Jun 05, 2024
P2P & T&E Business Partner (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Jun 12, 2024
R2R Senior Specialist GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Jun 13, 2024
Global Digital FRA Automation Lead Hyderabad (Office) India Finance Corporate Audit & Finance Jun 20, 2024
Senior Financial Reporting and Accounting Specialist Prague Czech Republic Finance CTS Audit & Finance Jul 03, 2024
Tax Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Jul 22, 2024
R2R Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Jul 28, 2024
Senior Accountant, Tax Shanghai (Shanghai) China Finance Corporate Audit & Finance Aug 29, 2024

Pagination

  • 1
  • 2
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia